Coegin Pharma
8.3 SEK +18.57%1 investor is following this company
Coegin Pharma is a Swedish biotechnology company with projects in hair growth, heart attack, leukemia and skin cancer. The company's business concept is to develop products in areas where there is a lack of satisfactory treatments and where there is potential for early exit. What the projects have in common is that they are based on patented technology platforms and collaborations with researchers and academics internationally. Coegin Pharma has its headquarters in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Nordic SME
COEGIN
Daily low / high price
7.18 / 8.8
SEK
Market cap
169.2M SEK
Turnover
1.14M SEK
Volume
142K
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-21
Annual report
2025-02-27
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Alveco Invest | 11.3 % | 11.3 % |
Nordnet Pensionsförsäkring | 10.5 % | 10.5 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Coegin Pharma AB's shares dual-listed on Börse Stuttgart as of today, July 1, 2024
Coegin Pharma AB:s aktier parallellnoteras på Börse Stuttgart från och med idag den 1 juli 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools